Literature DB >> 26481244

A methodology for comprehensive breast cancer Ki67 labeling index with intra-tumor heterogeneity appraisal based on hexagonal tiling of digital image analysis data.

Benoit Plancoulaine1, Aida Laurinaviciene2,3, Paulette Herlin4, Justinas Besusparis5,6, Raimundas Meskauskas7,8, Indra Baltrusaityte9,10, Yasir Iqbal11, Arvydas Laurinavicius12,13.   

Abstract

Digital image analysis (DIA) enables higher accuracy, reproducibility, and capacity to enumerate cell populations by immunohistochemistry; however, the most unique benefits may be obtained by evaluating the spatial distribution and intra-tissue variance of markers. The proliferative activity of breast cancer tissue, estimated by the Ki67 labeling index (Ki67 LI), is a prognostic and predictive biomarker requiring robust measurement methodologies. We performed DIA on whole-slide images (WSI) of 302 surgically removed Ki67-stained breast cancer specimens; the tumour classifier algorithm was used to automatically detect tumour tissue but was not trained to distinguish between invasive and non-invasive carcinoma cells. The WSI DIA-generated data were subsampled by hexagonal tiling (HexT). Distribution and texture parameters were compared to conventional WSI DIA and pathology report data. Factor analysis of the data set, including total numbers of tumor cells, the Ki67 LI and Ki67 distribution, and texture indicators, extracted 4 factors, identified as entropy, proliferation, bimodality, and cellularity. The factor scores were further utilized in cluster analysis, outlining subcategories of heterogeneous tumors with predominant entropy, bimodality, or both at different levels of proliferative activity. The methodology also allowed the visualization of Ki67 LI heterogeneity in tumors and the automated detection and quantitative evaluation of Ki67 hotspots, based on the upper quintile of the HexT data, conceptualized as the "Pareto hotspot". We conclude that systematic subsampling of DIA-generated data into HexT enables comprehensive Ki67 LI analysis that reflects aspects of intra-tumor heterogeneity and may serve as a methodology to improve digital immunohistochemistry in general.

Entities:  

Keywords:  Automated image analysis; Breast cancer; Digital pathology; Heterogeneity; Immunohistochemistry; Ki67

Year:  2015        PMID: 26481244     DOI: 10.1007/s00428-015-1865-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  24 in total

Review 1.  Digital image analysis: a review of reproducibility, stability and basic requirements for optimal results.

Authors:  Rikke Riber-Hansen; Ben Vainer; Torben Steiniche
Journal:  APMIS       Date:  2011-12-19       Impact factor: 3.205

2.  Geometric transformations on the hexagonal grid.

Authors:  I Her
Journal:  IEEE Trans Image Process       Date:  1995       Impact factor: 10.856

3.  Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer.

Authors:  Jason R Brown; Michael P DiGiovanna; Brigid Killelea; Donald R Lannin; David L Rimm
Journal:  Lab Invest       Date:  2013-11-04       Impact factor: 5.662

4.  Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue.

Authors:  Steven J Potts; Joseph S Krueger; Nicholas D Landis; David A Eberhard; G David Young; Steven C Schmechel; Holger Lange
Journal:  Lab Invest       Date:  2012-07-16       Impact factor: 5.662

5.  Intratumoral heterogeneity in primary breast carcinoma: study of concurrent parameters.

Authors:  L G Dodd; B J Kerns; R K Dodge; L J Layfield
Journal:  J Surg Oncol       Date:  1997-04       Impact factor: 3.454

6.  The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer.

Authors:  Matthias Christgen; Sabrina von Ahsen; Henriette Christgen; Florian Länger; Hans Kreipe
Journal:  Hum Pathol       Date:  2015-05-30       Impact factor: 3.466

7.  Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer.

Authors:  Einar Gudlaugsson; Ivar Skaland; Emiel A M Janssen; Rune Smaaland; Zhiming Shao; Anais Malpica; Feja Voorhorst; Jan P A Baak
Journal:  Histopathology       Date:  2012-09-11       Impact factor: 5.087

8.  Cellular sociology of proliferating tumor cells in invasive ductal breast cancer.

Authors:  G Haroske; V Dimmer; D Steindorf; U Schilling; F Theissig; K D Kunze
Journal:  Anal Quant Cytol Histol       Date:  1996-06       Impact factor: 0.302

Review 9.  Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic.

Authors:  Daniel E Carvajal-Hausdorf; Kurt A Schalper; Veronique M Neumeister; David L Rimm
Journal:  Lab Invest       Date:  2014-12-15       Impact factor: 5.662

10.  Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.

Authors:  A Goldhirsch; E P Winer; A S Coates; R D Gelber; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2013-08-04       Impact factor: 32.976

View more
  17 in total

1.  Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma.

Authors:  Arvydas Laurinavicius; Benoit Plancoulaine; Allan Rasmusson; Justinas Besusparis; Renaldas Augulis; Raimundas Meskauskas; Paulette Herlin; Aida Laurinaviciene; Abir A Abdelhadi Muftah; Islam Miligy; Mohammed Aleskandarany; Emad A Rakha; Andrew R Green; Ian O Ellis
Journal:  Virchows Arch       Date:  2016-01-27       Impact factor: 4.064

2.  Europe Unites for the Digital Transformation of Pathology: The Role of the New ESDIP.

Authors:  Catarina Eloy; Norman Zerbe; Filippo Fraggetta
Journal:  J Pathol Inform       Date:  2021-03-12

3.  SlideJ: An ImageJ plugin for automated processing of whole slide images.

Authors:  Vincenzo Della Mea; Giulia L Baroni; David Pilutti; Carla Di Loreto
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

4.  Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma.

Authors:  Dovile Zilenaite; Allan Rasmusson; Renaldas Augulis; Justinas Besusparis; Aida Laurinaviciene; Benoit Plancoulaine; Valerijus Ostapenko; Arvydas Laurinavicius
Journal:  Front Oncol       Date:  2020-06-16       Impact factor: 6.244

5.  [18F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [18F]FDG in human xenograft models.

Authors:  Narinée Hovhannisyan; Fabien Fillesoye; Stéphane Guillouet; Méziane Ibazizene; Jérôme Toutain; Fabienne Gourand; Samuel Valable; Benoit Plancoulaine; Louisa Barré
Journal:  Theranostics       Date:  2018-08-10       Impact factor: 11.556

6.  Focused scores enable reliable discrimination of small differences in steatosis.

Authors:  André Homeyer; Seddik Hammad; Lars Ole Schwen; Uta Dahmen; Henning Höfener; Yan Gao; Steven Dooley; Andrea Schenk
Journal:  Diagn Pathol       Date:  2018-09-20       Impact factor: 2.644

7.  Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods.

Authors:  Thaer Khoury; Gary Zirpoli; Stephanie M Cohen; Joseph Geradts; Angela Omilian; Warren Davis; Wiam Bshara; Ryan Miller; Michelle M Mathews; Melissa Troester; Julie R Palmer; Christine B Ambrosone
Journal:  Am J Clin Pathol       Date:  2017-08-01       Impact factor: 2.493

8.  Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer.

Authors:  Justinas Besusparis; Benoit Plancoulaine; Allan Rasmusson; Renaldas Augulis; Andrew R Green; Ian O Ellis; Aida Laurinaviciene; Paulette Herlin; Arvydas Laurinavicius
Journal:  Diagn Pathol       Date:  2016-08-30       Impact factor: 2.644

9.  Characterizing the heterogeneity of tumor tissues from spatially resolved molecular measures.

Authors:  John F Graf; Maria I Zavodszky
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

10.  Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.

Authors:  Timco Koopman; Henk J Buikema; Harry Hollema; Geertruida H de Bock; Bert van der Vegt
Journal:  Breast Cancer Res Treat       Date:  2018-01-18       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.